{
    "clinical_study": {
        "@rank": "87345", 
        "arm_group": [
            {
                "arm_group_label": "Generally healthy", 
                "description": "Generally healthy"
            }, 
            {
                "arm_group_label": "Type 2 diabetes mellitus", 
                "description": "Type 2 diabetes mellitus"
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The rationale for this trial is to apply a simple and minimally strenuous pre-screening\n      approach prior to performing more extensive trial-specific screening and\n      baseline-characterization activities in the resulting pre-selected population of subjects."
        }, 
        "brief_title": "Explorative Assessment of Biomarkers in Overweight and Obese Subjects", 
        "condition": "Prediabetes", 
        "condition_browse": {
            "mesh_term": [
                "Glucose Intolerance", 
                "Prediabetic State", 
                "Overweight"
            ]
        }, 
        "detailed_description": {
            "textblock": "The pre-screening assessments are designed to characterize the metabolic risk profile /\n      prediabetic status in an unselected population of overweight and obese volunteers, aiming to\n      pre-select high risk and prediabetic subjects as a target population who may specifically\n      profit from primary diabetes intervention (prevention) strategies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Obese and overweight subjects\n\n          -  Considered generally healthy\n\n        Exclusion Criteria:\n\n          -  Clinically significant acute illness within 2 weeks before study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Generally healthy or Type 2 Diabetes mellitus"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01910051", 
            "org_study_id": "OBDM-01"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Neuss", 
                    "country": "Germany", 
                    "zip": "41460"
                }, 
                "name": "Profil Institut f\u00fcr Stoffwechselforschung GmbH"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "Explorative Assessment of Biomarkers Indicative of Insulin Resistance and Prediabetes in Overweight and Obese Subjects", 
        "other_outcome": {
            "description": "assessment of study data at the end of the study", 
            "measure": "the correlation between anthropometric data, medical history, and biomarkers with regard to metabolic risk", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "overall_official": {
            "affiliation": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
            "last_name": "Leona Plum-M\u00f6rschel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Germany: not applicable", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "One blood sample taken on day 1 of the study", 
            "measure": "anthropometric measures and metabolic biomarkers indicative of prediabetes", 
            "safety_issue": "No", 
            "time_frame": "Day one"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01910051"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Several circulating markers including the traditionally used fasting serum insulin and fasting plasma glucose as well as an oral glucose tolerance test may serve as indicators of prediabetes. Importantly, these parameters show considerable intra-individual short-term variability. The assessments will therefore be repeated three times within a one month period to determine intra-subject variability of the analyzed parameters under the conditions that apply to the trial site and experimental conditions.", 
            "measure": "intra-subject and inter-subject variability of analyzed biomarkers", 
            "safety_issue": "No", 
            "time_frame": "within one month"
        }, 
        "source": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}